Literature DB >> 428689

Control of blood glucose levels in the streptozotocin diabetic rat using a long-acting heat-treated insulin.

R Rasch.   

Abstract

Diurnal plasma glucose levels have been studied two hourly in streptozotocin diabetic rats during insulin treatment. Protamine Zinc Insulin induced a very steep fall in plasma glucose level from 359 +/- 100 (SD) mg/100 ml to 91 +/- 49 mg/100 ml within two hours. Plasma glucose was then low (13-60 mg/100 ml) until after 18 hours when an equally steep rise in glucose concentration ocurred. Six other insulin preparations and several insulin treatment regimens were tested with the aim of normalising the 24 hour plasma glucose profile of streptozotocin diabetic rats. One preparation, a non-commercial, very long acting Ultralente NOVO (Mc, ox pH 5.5) yielded a diurnal plasma glucose profile reasonably close to normal when it was administered once a day and when the dose was based on daily blood glucose measurements. Mean plasma glucose was 122 +/- 55 mg/100 ml with a nadir of 55 +/- 15 and a maximal of 187 +/- 99 mg/100 ml.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 428689     DOI: 10.1007/bf01219796

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  Effect of insulin on glycosuria, polyuria and food intake in alloxanized rats.

Authors:  F M STURTEVANT
Journal:  Diabetes       Date:  1956 Sep-Oct       Impact factor: 9.461

2.  Peripheral nerves in early experimental diabetes: expansion of the endoneurial space as a cause of increased water content.

Authors:  J Jakobsen
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

3.  Kidney lesions in rats with severe long-term alloxan diabetes : I. Influence of age, alloxan damage, and insulin administration.

Authors:  H Orskov; T Steen Olsen; K Nielsen; O J Rafaelsen; K Lundbaek
Journal:  Diabetologia       Date:  1966-04       Impact factor: 10.122

4.  Influence of insulin treatment on glomerular changes in rats with long-term alloxan diabetes.

Authors:  E Hägg
Journal:  Acta Pathol Microbiol Scand A       Date:  1974-03

5.  "Instant" blood sugar measurement using Dextrostix and a reflectance meter.

Authors:  R J Jarrett; H Keen; C Hardwick
Journal:  Diabetes       Date:  1970-10       Impact factor: 9.461

6.  Notes on the glucose oxidase method.

Authors:  N J Christensen
Journal:  Scand J Clin Lab Invest       Date:  1967       Impact factor: 1.713

7.  Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.

Authors:  D A Greene; P V De Jesus; A I Winegrad
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

8.  Fast and slow axoplasmic flow in sciatic nerve of diabetic rats.

Authors:  R E Schmidt; F M Matschinsky; D A Godfrey; A D Williams; D B McDougal
Journal:  Diabetes       Date:  1975-12       Impact factor: 9.461

9.  Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. Kidney size and glomerular volume.

Authors:  R Rasch
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

10.  Experimental diabetic ketoacidosis. Sequential changes of metabolic intermediates in blood, liver, cerebrospinal fluid and brain after acute insulin deprivation in the streptozotocin-diabetic rat.

Authors:  P J Blackshear; K G Alberti
Journal:  Biochem J       Date:  1974-01       Impact factor: 3.857

View more
  24 in total

1.  Exogenous hyperglucagonaemia in insulin controlled diabetic rats increases urea excretion and nitrogen loss from organs.

Authors:  T P Almdal; H Vilstrup
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

2.  Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals.

Authors:  C F Gotfredsen; K Buschard; E K Frandsen
Journal:  Diabetologia       Date:  1985-12       Impact factor: 10.122

3.  Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. The mesangial regions.

Authors:  R Rasch
Journal:  Diabetologia       Date:  1979-10       Impact factor: 10.122

4.  Is human insulin without effect in the diabetic rat?

Authors:  O Torffvit
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

5.  Insulin stimulates skeletal growth in vivo and in vitro--comparison with growth hormone in rats.

Authors:  E Heinze; U Vetter; K H Voigt
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

6.  Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: effects of insulin or aldose reductase inhibition.

Authors:  E J Stevens; G B Willars; P Lidbury; F House; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  The impact of renal growth, regression and regrowth in experimental diabetes mellitus on number and size of proximal and distal tubular cells in the rat kidney.

Authors:  J R Nyengaard; A Flyvbjerg; R Rasch
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

8.  The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes.

Authors:  J R Nyengaard; R Rasch
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

9.  Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.

Authors:  R Zatz; T W Meyer; H G Rennke; B M Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models.

Authors:  E J Stevens; A L Carrington; D R Tomlinson
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.